Importance of Dietary γ-Linolenic Acid in Human Health and Nutrition

Considerable debate remains regarding the distinct biological activities of individual polyunsaturated fatty acids (PUFA). One of the most interesting yet controversial dietary approaches has been the possible prophylactic role of dietary gamma-linolenic acid (GLA) in treating various chronic disease states. This strategy is based on the ability of diet to modify cellular lipid composition and eicosanoid (cyclooxygenase and lipoxygenase) biosynthesis. Recent studies demonstrate that dietary GLA increases the content of its elongase product, dihomo-gamma-linolenic acid (DGLA), within cell membranes without concomitant changes in arachidonic acid (AA). Subsequently, upon stimulation, DGLA can be converted by inflammatory cells to 15-(S)-hydroxy-8,11,13-eicosatrienoic acid and prostaglandin E1. This is noteworthy because these compounds possess both anti-inflammatory and antiproliferative properties. Although an optimal feeding regimen to maximize the potential benefits of dietary GLA has not yet been determined, it is the purpose of this review to summarize the most recent research that has focused on objectively and reproducibly determining the mechanism(s) by which GLA may ameliorate health problems.

[1]  V. Ziboh,et al.  A novel 15-hydroxyeicosatrienoic acid-substituted diacylglycerol (15-HETrE-DAG) selectively inhibits epidermal protein kinase C-beta. , 1997, Biochimica et biophysica acta.

[2]  M. Laposata,et al.  Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation , 1997, Journal of leukocyte biology.

[3]  K. Ramos,et al.  Dietary γ-Linolenic Acid Enhances Mouse Macrophage-Derived Prostaglandin E1 Which Inhibits Vascular Smooth Muscle Cell Proliferation , 1997 .

[4]  M. Woodward,et al.  Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet , 1997, European Journal of Clinical Nutrition.

[5]  R. Mansel,et al.  Gamma linolenic acid regulates expression of maspin and the motility of cancer cells. , 1997, Biochemical and biophysical research communications.

[6]  A. Fonteh,et al.  Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. , 1997, The Journal of nutrition.

[7]  A. Yamashita,et al.  Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. , 1997, Journal of biochemistry.

[8]  G. Condorelli,et al.  Activation of cAMP–PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury , 1997, Nature Medicine.

[9]  Y. Naito,et al.  Efficacy of hyperthermia and polyunsaturated fatty acids on experimental carcinoma. , 1997, Cancer research.

[10]  G. Tsokos,et al.  Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3-mediated signal transduction pathway in human T cells. , 1997, Clinical immunology and immunopathology.

[11]  R. Chapkin,et al.  Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. , 1997, The Journal of nutrition.

[12]  P. Sassone-Corsi,et al.  Transcription factors coupled to the cAMP-signalling pathway. , 1996, Biochimica et biophysica acta.

[13]  H. Okuyama,et al.  Dietary fatty acids--the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan. , 1996, Progress in lipid research.

[14]  M. Laposata,et al.  gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. , 1996, Arthritis and rheumatism.

[15]  K. Ramos,et al.  Dietary lipid source alters murine macrophage/vascular smooth muscle cell interactions in vitro. , 1996, The Journal of nutrition.

[16]  A. Fields,et al.  βII Protein Kinase C Is Required for the G2/M Phase Transition of Cell Cycle* , 1996, The Journal of Biological Chemistry.

[17]  T. Thomas,et al.  Expression of a cyanobacterial Δ6-desaturase gene results in γ-linolenic acid production in transgenic plants , 1996, Nature Biotechnology.

[18]  K. Ramos,et al.  Cell cycle related inhibition of mouse vascular smooth muscle cell proliferation by prostaglandin E1: relationship between prostaglandin E1 and intracellular cAMP levels. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.

[19]  Osamu Hiruta,et al.  Optimization and scale-up of γ-linolenic acid production by Mortierella ramanniana MM 15-1, a high γ-linolenic acid producing mutant , 1996 .

[20]  R. Mansel,et al.  Regulation of the Expression of E-Cadherin on Human Cancer Cells by γ-Linolenic Acid (GLA) , 1995 .

[21]  K. Ramos,et al.  Dietary γ-Linolenic Acid Modulates Macrophage–Vascular Smooth Muscle Cell Interactions Evidence for a Macrophage-Derived Soluble Factor That Downregulates DNA Synthesis in Smooth Muscle Cells , 1995 .

[22]  P. Deluca,et al.  Marine and botanical lipids as immunomodulatory and therapeutic agents in the treatment of rheumatoid arthritis. , 1995, Rheumatic diseases clinics of North America.

[23]  M. Cotter,et al.  Comparison of the effects of evening primrose oil and triglycerides containing gamma-linolenic acid on nerve conduction and blood flow in diabetic rats. , 1995, The Journal of pharmacology and experimental therapeutics.

[24]  B. Koller,et al.  Altered inflammatory responses in leukotriene-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Hayward.  Purchasing clinically effective care , 1994, BMJ.

[26]  R. Rossetti,et al.  Suppression of acute inflammation with liposome associated prostaglandin E1. , 1994, Prostaglandins.

[27]  E. Boyce,et al.  Treatment of Rheumatoid Arthritis with Gammalinolenic Acid , 1993, Annals of Internal Medicine.

[28]  R. Chapkin,et al.  Phospholipid sources of metabolically elongated gammalinolenic acid: Conversion to prostaglandin E1 in stimulated mouse macrophages , 1993 .

[29]  R. Chapkin,et al.  The effect of borage oil supplementation on human platelet aggregation, thromboxane B2, prostaglandin E1 and E2 formation , 1993 .

[30]  Y. Sugimoto,et al.  Prostanoid receptors and their biological actions. , 1993, Progress in lipid research.

[31]  R. Chapkin,et al.  Mouse peritoneal macrophage prostaglandin E1 synthesis is altered by dietary gamma-linolenic acid. , 1992, The Journal of nutrition.

[32]  C. Miller,et al.  Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites. , 1991, The Journal of investigative dermatology.

[33]  C. Miller,et al.  Ability of 15-hydroxyeicosatrienoic acid (15-OH-20:3) to modulate macrophage arachidonic acid metabolism. , 1988, Biochemical and biophysical research communications.

[34]  A. Willis,et al.  Antithrombotic potential of dihomo-gamma-linolenic acid in man. , 1977, British medical journal.

[35]  M. Hamberg,et al.  Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. , 1976, The Journal of biological chemistry.